Zimmer Biomet reports 4.8% YoY revenue uptick in Q2; raises 2026 outlook
Covered in this story
What has happened since
- Zimmer Biomet is down 2.5% since this was published, 76 days ago.
Price move measured from the close nearest publication to the latest quote.
Call it yourself
No calls on $ZBH yet. A scorecard is a price target with a date and the working behind it — tracked, settled and scored in public.
Make the first call on Zimmer Biomet →Summary aggregated from Yahoo Finance's public RSS feed. The full reporting belongs to Yahoo Finance — please read it on their site.